V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210038787 | 210006543 | 1.55 | 52 | Palliative (P) | 2018-05-29 | 2018-05-29 | Lomustine | 1 | N | 210010396 | LOMUSTINE |
| 210038788 | 210018557 | 1.85 | 77.4 | Palliative (P) | 2019-03-01 | 2019-03-01 | Lomustine | 2 | N | 210010778 | LOMUSTINE |
| 210038789 | 210006723 | null | null | Curative (C) | 2015-07-07 | 2015-07-11 | Lomustine | N | N | 210010917 | LOMUSTINE |
| 210038790 | 210006746 | 1.75 | 77.5 | Curative (C) | 2017-04-16 | 2017-04-21 | IBRUTINIB | 2 | N | 210010965 | IBRUTINIB |
| 210038791 | 210006764 | 1.63 | 94.65 | Adjuvant (A) | 2018-05-19 | 2019-02-07 | Rituximab | 02 | N | 210010978 | RITUXIMAB |
| 210038792 | 210006849 | 1.79 | 81.7 | Curative (C) | 2018-06-12 | 2018-06-13 | BENDAMUSTINE + RITUXIMAB | N | N | 210011203 | BENDAMUSTINE + RITUXIMAB |
| 210038793 | 210006925 | 1.85 | null | null | 2018-12-12 | 2018-12-12 | FCR Oral - Cycle 2 onwards | Y | null | 210011458 | FCR |
| 210038794 | 210007178 | 1.85 | 55.4 | Curative (C) | 2018-10-18 | 2019-03-01 | Triple / Double Intrathecal Therapy | N | N | 210012572 | TRIPLE INTRATHECAL |
| 210038795 | 210007596 | 1.68 | 72 | Curative (C) | 2020-03-19 | 2020-09-09 | ALL UKALL2003 TRIAL | Y | N | 210013640 | UKALL 2003 |
| 210038796 | 210007730 | 1.82 | 76.5 | Curative (C) | 2014-11-30 | 2015-08-23 | Venetoclax | Y | N | 210013914 | VENETOCLAX |
| 210038797 | 210007921 | 1.55 | null | Adjuvant (A) | 2015-03-28 | 2015-03-29 | Chlorambucil | N | N | 210014311 | CHLORAMBUCIL |
| 210038799 | 210008139 | null | 98 | Palliative (P) | 2015-09-06 | 2015-10-18 | MERCAPTOPURINE + METHOTREXATE | 2 | N | 210014747 | MERCAPTOPURINE + METHOTREXATE |
| 210038800 | 210008157 | 1.74 | 107.3 | Curative (C) | 2019-06-11 | 2019-07-05 | Procarbazine | N | N | 210014775 | PROCARBAZINE |
| 210038802 | 210008567 | null | 21.2 | Palliative (P) | 2018-06-02 | 2018-11-16 | IDELALISIB | N | N | 210015709 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 210038803 | 210010879 | 0 | 0 | Curative (C) | 2018-01-28 | 2018-05-15 | Docetaxel 75mg/m2 (21 day) | Y | N | 210027529 | BUSULFAN + FLUDARABINE + METHOTREXATE |
| 210038804 | 210012159 | 1.54 | 25.2 | Curative (C) | 2017-04-26 | 2017-04-27 | CVP | N | N | 210033375 | SIOP |
| 210038805 | 210013419 | 1.77 | null | Curative (C) | 2019-10-10 | 2019-10-10 | Hydroxycarbamide | N | N | 210040628 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 210038806 | 210013792 | 1.68 | null | Curative (C) | null | 2018-04-22 | IVAC | N | N | 210028705 | MITOMYCIN |
| 210038808 | 210038852 | 1.69 | 62 | Curative (C) | 2019-10-22 | 2019-10-25 | Temozolomide 200mg/m2 | N | N | 210002777 | TEMOZOLOMIDE |
| 210038809 | 210017530 | 1.53 | null | Palliative (P) | 2019-09-27 | 2019-12-27 | Temozolomide 200mg/m2 | N | N | 210004002 | TEMOZOLOMIDE |
| 210038810 | 210025022 | null | 102.3 | Curative (C) | 2015-09-17 | 2015-11-11 | CNS HGG Temozolomide maintenance | 2 | N | 210005198 | TEMOZOLOMIDE |
| 210038811 | 210005257 | 1.85 | 67.2 | Curative (C) | 2019-06-29 | 2019-08-13 | ALL UKALL2011 Aug BFM Cons C PegAsp | Y | N | 210005410 | UKALL2011 |
| 210038814 | 210005428 | 1.35 | 23 | Curative (C) | 2015-08-11 | 2016-03-04 | ALL UKALL2011 Del Int A Pt1 (PAsp) | Y | N | 210006133 | UKALL2011 |
| 210038815 | 210005477 | null | 48.9 | Curative (C) | 2017-10-06 | 2018-06-02 | ALL UKALL2011 Maintenance A3 | Y | N | 210006371 | UKALL2011 |
| 210038816 | 210017795 | 1.19 | 50 | Curative (C) | 2016-04-12 | 2016-10-22 | ALL UKALL2011 Del Int C Recon PAsp | Y | N | 210006602 | UKALL2011 |
| 210038818 | 210005640 | 0 | 17.1 | Curative (C) | 2017-06-21 | 2017-06-21 | ALL UKALL2011 Ind A Std Dex (PAsp) | Y | N | 210007091 | UKALL2011 |
| 210038820 | 210005708 | 1.56 | 15 | Curative (C) | 2017-07-11 | 2018-11-13 | ALL UKALL2011 Del Int C Recon PAsp | Y | N | 210007468 | UKALL2011 |
| 210038821 | 210005760 | null | 29.4 | Curative (C) | 2016-01-20 | 2016-03-16 | ALL UKALL2011 Del Int C Recon PAsp | Y | null | 210007627 | UKALL2011 |
| 210038822 | 210005850 | 0 | 60 | Curative (C) | 2015-06-19 | 2015-12-23 | ALL UKALL2011 Maintenance A1 | Y | N | 210007896 | UKALL2011 |
| 210038823 | 210005888 | 1.56 | 103.2 | Curative (C) | 2014-05-16 | 2014-11-15 | ALL UKALL2011 Maintenance A1 | Y | null | 210008060 | UKALL2011 |
| 210038824 | 210005900 | 1.78 | 17.7 | Curative (C) | 2015-05-30 | 2015-08-14 | ALL UKALL2011 Maintenance A2 | Y | N | 210008074 | UKALL 2011 |
| 210038826 | 210029999 | 0 | 30.2 | Curative (C) | 2017-07-26 | 2017-10-13 | ALL UKALL2011 Maintenance A2 | Y | N | 210008355 | UKALL 2011 |
| 210038827 | 210006007 | 1.54 | 0 | Curative (C) | 2017-01-11 | 2017-08-09 | Methotrexate Intrathecal (any age) | Y | N | 210008484 | METHOTREXATE INTRATHECAL |
| 210038829 | 210018154 | 0 | 12.9 | Curative (C) | 2013-11-19 | 2014-12-31 | Methotrexate intrathecal | N | N | 210008769 | METHOTREXATE INTRATHECAL |
| 210038830 | 210018164 | 1.68 | 74.7 | Curative (C) | 2015-12-01 | 2016-07-17 | UKALL14- Ph 2 Induction | N | N | 210008823 | UKALL2014 |
| 210038831 | 210018173 | null | 74.2 | Curative (C) | 2019-11-09 | 2020-02-15 | UKALL14- Maintenance | Y | null | 210008880 | UKALL2014 |
| 210038832 | 210006222 | 1.71 | 73.1 | Curative (C) | 2017-04-09 | 2017-04-09 | UKALL14- Cons Cycle 1 | Y | null | 210009402 | UKALL2014 |
| 210038833 | 210006241 | 1.74 | 106.3 | Curative (C) | 2018-01-15 | 2018-01-15 | UKALL14- Cons Cycle 1 | Y | Y | 210009453 | UKALL2014 |
| 210038834 | 210006284 | 1.77 | 84.9 | Curative (C) | 2015-03-14 | 2015-05-09 | UKALL14- Ph 2 Induction | Y | null | 210009681 | UKALL2014 |
| 210038835 | 210006299 | 1.69 | 47 | Curative (C) | 2017-04-24 | 2017-05-28 | UKALL14- Ph 2 Induction | Y | N | 210009764 | UKALL2014 |
| 210038836 | 210006307 | 1.77 | null | Disease modification (D) | 2014-07-17 | 2014-07-22 | UKALL14- Maintenance | null | N | 210009769 | UKALL2014 |
| 210038837 | 210006339 | 1.77 | 60.5 | Curative (C) | 2017-08-01 | 2017-08-29 | UKALL14- Maintenance | Y | N | 210009828 | UKALL2014 |
| 210038838 | 210006347 | null | 16.4 | Curative (C) | 2016-12-30 | 2017-01-06 | CNS PNET 5 Medbl L/StRsk Mnt A Cis | N | N | 210009833 | NOT MATCHED |
| 210038839 | 210006373 | 0 | 14.6 | Curative (C) | 2016-04-11 | 2016-06-13 | null | N | N | 210009866 | NOT MATCHED |
| 210038840 | 210006422 | null | 65.1 | Adjuvant (A) | 2016-11-19 | 2016-12-13 | CNS Headstart II C Ind 1,2,3 | N | Y | 210010026 | NOT MATCHED |
| 210038841 | 210006435 | 0 | 75.4 | Curative (C) | 2017-02-06 | 2017-08-13 | Trial Unspecified | Y | null | 210010067 | TRIAL |
| 210038842 | 210006489 | null | null | Adjuvant (A) | 2018-09-12 | 2020-05-21 | IBRUTINIB | 02 | N | 210010213 | IBRUTINIB |
| 210038844 | 210006520 | 1.63 | 70.4 | Palliative (P) | 2016-09-29 | 2016-10-27 | BENDAMUSTINE + RITUXIMAB | N | N | 210010330 | BENDAMUSTINE + RITUXIMAB |
| 210038845 | 210006723 | 1.66 | 80 | Palliative (P) | 2015-08-08 | 2015-08-08 | Bendamustine+Rituximab (1st Course) | N | N | 210010917 | BENDAMUSTINE + RITUXIMAB |
| 210038846 | 210030357 | 0 | 91.3 | Curative (C) | 2017-04-16 | 2017-04-23 | Chlorambucil + Pred + Rituximab | Y | N | 210010965 | CHLORAMBUCIL + RITUXIMAB |